Deiva K, Huppke P, Banwell B, et al. Effect of fingolimod in pediatric MS: further insights from sensitivity, supportive and post-hoc analyses from PARADIGMS. AAN 2018, emerging science abstract 005.,Menascu S, Milo R, Magalashvili D, et al. Natalizumab treatment for highly active children and juveniles multiple sclerosis patients : An Israeli collaborative study. AAN 2018, S35.001.
Brentuximab vedotine plus chemotherapie bij kinderen met hoogrisico hodgkinlymfoom
jan 2023 | Lymfoom